Skip to main content

International Biotechnology Trust PLC

13F filer · CIK 0000942257
Last filed Nov 14, 2023
Inactive · not filing 13F
13F portfolio value$297MU.S. long equity reported on 13F
Positions659 new · 5 closed
Net flow last quarter-$12.9MBuys minus sells
Top 10 positions weight47.8%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q3 2023Reported Nov 14, 202365 positions
AMGNAmgen Inc$21.3M7.17%0.01%-32.4%Q4 2016
INCYIncyte Corp$20.7M6.97%0.16%Not reportedQ4 2016
GILDGilead Sciences, Inc.$17.5M5.90%0.02%+61.6%Q4 2016
ITCIIntra-Cellular Therapies, Inc.$16.5M5.57%0.33%+79.7%Q1 2020
BMRNBiomarin Pharmaceutical Inc$13.6M4.58%0.08%+162.0%Q4 2016
SUPNSupernus Pharmaceuticals, Inc.$11.8M3.96%0.79%-18.5%Q1 2017
VERAVera Therapeutics, Inc.$10.4M3.50%1.71%-22.2%Q4 2021
BIIBBiogen Inc.$10.3M3.48%0.03%+265.5%Q4 2016
HRMYHarmony Biosciences Holdings, Inc.$10.3M3.47%0.54%-44.9%Q2 2021
MRTXMirati Therapeutics, Inc.$9.4M3.17%0.31%-16.9%Q1 2019
RAREUltragenyx Pharmaceutical Inc.$8.91M3.00%0.35%+212.4%Q1 2018
QUREuniQure N.V.$8.33M2.81%2.60%+7909.7%Q2 2019
AUPHAurinia Pharmaceuticals Inc.$8.07M2.72%0.72%+81.4%Q3 2020
UTHRUNITED THERAPEUTICS Corp$7.66M2.58%0.07%-35.6%Q1 2021
VRTXVertex Pharmaceuticals Inc / Ma$7.3M2.46%0.01%Not reportedQ4 2016
REGNRegeneron Pharmaceuticals, Inc.$7.28M2.45%0.01%-67.2%Q4 2016
ILMNIllumina, Inc.$6.93M2.34%0.03%Not reportedQ4 2016
ALNYAlnylam Pharmaceuticals, Inc.$6.52M2.20%0.03%-54.9%Q3 2017
AMLXAmylyx Pharmaceuticals, Inc.$5.4M1.82%0.44%+1080.0%Q2 2023
KRYSKrystal Biotech, Inc.$5.34M1.80%0.16%+0.3%Q4 2021
KRTXKaruna Therapeutics, Inc.$5.16M1.74%0.08%+18.7%Q2 2022
AXSMAxsome Therapeutics, Inc.$4.07M1.37%0.12%Not reportedQ4 2020
ERASErasca, Inc.$3.79M1.28%1.28%+35.1%Q1 2023
ACADAcadia Pharmaceuticals Inc$3.74M1.26%0.11%+19.0%Q4 2016
RVNCRevance Therapeutics, Inc.$3.31M1.11%0.33%Not reportedQ3 2022
NBIXNeurocrine Biosciences Inc$3.25M1.09%0.03%-58.1%Q4 2016
SRPTSarepta Therapeutics, Inc.$3.23M1.09%0.03%+42.0%Q4 2016
RCKTRocket Pharmaceuticals, Inc.$3.19M1.08%0.17%Not reportedQ3 2021
DNLIDenali Therapeutics Inc.$3.17M1.07%0.11%-18.1%Q4 2021
AZNAstrazeneca PLC$3.15M1.06%Not reportedNot reportedQ4 2022
XENEXenon Pharmaceuticals Inc.$3.12M1.05%0.14%+258.8%Q2 2021
CRSPCRISPR Therapeutics AG$2.86M0.96%0.08%Not reportedQ4 2019
MDGLMadrigal Pharmaceuticals, Inc.$2.67M0.90%0.10%Not reportedQ4 2017
LEGNLegend Biotech Corp$2.55M0.86%0.01%Not reportedQ3 2021
HALOHalozyme Therapeutics, Inc.$2.38M0.80%0.05%-34.9%Q4 2016
MRNSMarinus Pharmaceuticals, Inc.$2.34M0.79%0.53%+222.2%Q2 2023
ONCBeOne Medicines Ltd.$2.28M0.77%0.00%+46.0%Q1 2017
JAZZJazz Pharmaceuticals plc$2.23M0.75%0.03%Not reportedQ4 2016
MIRMMirum Pharmaceuticals, Inc.$2.13M0.72%0.14%Not reportedQ3 2022
IOVAIovance Biotherapeutics, Inc.$2.02M0.68%0.17%+584.6%Q2 2019
IONSIonis Pharmaceuticals Inc$1.95M0.66%0.03%Not reportedQ1 2017
ZLABZai Lab Ltd$1.92M0.65%0.01%Not reportedQ2 2021
GMABGenmab A/S$1.56M0.53%Not reportedNot reportedQ2 2022
CLDXCelldex Therapeutics, Inc.$1.32M0.45%0.10%Not reportedQ2 2023
COGTCogent Biosciences, Inc.$1.31M0.44%0.16%NewQ3 2023
DYNDyne Therapeutics, Inc.$1.23M0.41%0.22%-54.2%Q1 2021
NVCRNovoCure Ltd$1.19M0.40%0.07%+131.3%Q4 2019
FOLDAmicus Therapeutics, Inc.$1.09M0.37%0.03%Not reportedQ4 2016
CYTKCytokinetics Inc$1.09M0.37%0.04%Not reportedQ3 2020
GHGuardant Health, Inc.$1.08M0.36%0.03%Not reportedQ2 2021
Q2 2023Reported Aug 8, 202361 positions
AMGNAmgen Inc$26M7.92%0.02%+28.5%Q4 2016
INCYIncyte Corp$22.3M6.79%0.16%+28.5%Q4 2016
HRMYHarmony Biosciences Holdings, Inc.$20.1M6.11%0.95%Not reportedQ2 2021
REGNRegeneron Pharmaceuticals, Inc.$19.4M5.91%0.03%+141.1%Q4 2016
SUPNSupernus Pharmaceuticals, Inc.$15.7M4.79%0.96%+23.6%Q1 2017
VERAVera Therapeutics, Inc.$15.6M4.76%2.20%-2.7%Q4 2021
ALNYAlnylam Pharmaceuticals, Inc.$15.5M4.72%0.07%+75.1%Q3 2017
APLSApellis Pharmaceuticals, Inc.$11.8M3.60%0.11%+309.2%Q1 2021
UTHRUNITED THERAPEUTICS Corp$11.6M3.55%0.11%+85.1%Q1 2021
ITCIIntra-Cellular Therapies, Inc.$11.2M3.40%0.18%-31.4%Q1 2020
GILDGilead Sciences, Inc.$11.1M3.39%0.01%+151.1%Q4 2016
ILMNIllumina, Inc.$9.46M2.88%0.03%+90.6%Q4 2016
MRTXMirati Therapeutics, Inc.$9.39M2.86%0.45%+6.6%Q1 2019
VRTXVertex Pharmaceuticals Inc / Ma$7.39M2.25%0.01%-36.4%Q4 2016
RVNCRevance Therapeutics, Inc.$7.3M2.22%0.33%+57.8%Q3 2022
HZNPHorizon Therapeutics Public Ltd Co$6.89M2.10%0.03%Not reportedQ4 2016
TVTXTravere Therapeutics, Inc.$6.77M2.06%0.59%+212.7%Q4 2020
NBIXNeurocrine Biosciences Inc$6.49M1.98%0.07%Not reportedQ4 2016
KRTXKaruna Therapeutics, Inc.$5.57M1.69%0.07%+133.6%Q2 2022
AUPHAurinia Pharmaceuticals Inc.$5.55M1.69%0.40%Not reportedQ3 2020
DNLIDenali Therapeutics Inc.$5.54M1.69%0.14%+117.2%Q4 2021
KRYSKrystal Biotech, Inc.$5.39M1.64%0.16%-24.7%Q4 2021
BMRNBiomarin Pharmaceutical Inc$5.08M1.55%0.03%Not reportedQ4 2016
MDGLMadrigal Pharmaceuticals, Inc.$4.23M1.29%0.10%Not reportedQ4 2017
AXSMAxsome Therapeutics, Inc.$4.19M1.27%0.12%Not reportedQ4 2020
ERASErasca, Inc.$3.92M1.19%0.95%Not reportedQ1 2023
RAREUltragenyx Pharmaceutical Inc.$3.69M1.12%0.11%-69.7%Q1 2018
AKROAkero Therapeutics, Inc.$3.66M1.11%0.14%NewQ2 2023
ACADAcadia Pharmaceuticals Inc$3.62M1.10%0.09%-30.1%Q4 2016
HALOHalozyme Therapeutics, Inc.$3.44M1.05%0.07%+109.9%Q4 2016
DYNDyne Therapeutics, Inc.$3.38M1.03%0.49%-30.7%Q1 2021
BIIBBiogen Inc.$3.13M0.95%0.01%-48.6%Q4 2016
RCKTRocket Pharmaceuticals, Inc.$3.09M0.94%0.19%+147.6%Q3 2021
LEGNLegend Biotech Corp$2.62M0.80%0.01%Not reportedQ3 2021
ZLABZai Lab Ltd$2.19M0.67%0.01%Not reportedQ2 2021
SRPTSarepta Therapeutics, Inc.$2.15M0.66%0.02%Not reportedQ4 2016
JAZZJazz Pharmaceuticals plc$2.13M0.65%0.03%Not reportedQ4 2016
IONSIonis Pharmaceuticals Inc$1.76M0.54%0.03%Not reportedQ1 2017
MIRMMirum Pharmaceuticals, Inc.$1.74M0.53%0.18%Not reportedQ3 2022
CLDXCelldex Therapeutics, Inc.$1.63M0.50%0.10%NewQ2 2023
ONCBeOne Medicines Ltd.$1.55M0.47%0.00%-61.7%Q1 2017
NVCRNovoCure Ltd$1.33M0.40%0.03%Not reportedQ4 2019
GHGuardant Health, Inc.$1.31M0.40%0.03%-51.0%Q2 2021
CYTKCytokinetics Inc$1.21M0.37%0.04%Not reportedQ3 2020
XENEXenon Pharmaceuticals Inc.$982K0.30%0.04%Not reportedQ2 2021
NTLAIntellia Therapeutics, Inc.$978K0.30%0.03%Not reportedQ4 2021
MRNSMarinus Pharmaceuticals, Inc.$977K0.30%0.18%NewQ2 2023
SAGESage Therapeutics, Inc.$939K0.29%0.03%Not reportedQ4 2016
NBPNovaBridge Biosciences$925K0.28%0.16%Not reportedQ1 2021
INSMINSMED Inc$845K0.26%0.03%Not reportedQ1 2019
Q1 2023Reported May 18, 202361 positions
AMGNAmgen Inc$22.1M6.15%0.02%+461.7%Q4 2016
INCYIncyte Corp$20.2M5.63%0.13%+21.8%Q4 2016
HRMYHarmony Biosciences Holdings, Inc.$18.6M5.20%0.95%+115.7%Q2 2021
ALKSAlkermes plc.$16.7M4.66%0.36%Not reportedQ1 2019
SUPNSupernus Pharmaceuticals, Inc.$15.3M4.28%0.78%+10.4%Q1 2017
ITCIIntra-Cellular Therapies, Inc.$14M3.89%0.27%+16.2%Q1 2020
RAREUltragenyx Pharmaceutical Inc.$10.6M2.95%0.37%+51.7%Q1 2018
EXELExelixis, Inc.$10.5M2.94%0.17%Not reportedQ4 2016
VRTXVertex Pharmaceuticals Inc / Ma$10.4M2.90%0.01%Not reportedQ4 2016
QUREuniQure N.V.$9.64M2.69%1.01%-24.2%Q2 2019
ALNYAlnylam Pharmaceuticals, Inc.$9.33M2.60%0.04%+22.6%Q3 2017
REGNRegeneron Pharmaceuticals, Inc.$9.2M2.57%0.01%Not reportedQ4 2016
MRTXMirati Therapeutics, Inc.$9.07M2.53%0.42%Not reportedQ1 2019
SNYSanofi$7.81M2.18%0.01%Not reportedQ2 2022
VERAVera Therapeutics, Inc.$7.75M2.16%3.62%+256.4%Q4 2021
UTHRUNITED THERAPEUTICS Corp$6.38M1.78%0.06%+90.0%Q1 2021
AUPHAurinia Pharmaceuticals Inc.$6.28M1.75%0.40%Not reportedQ3 2020
ILMNIllumina, Inc.$6.16M1.72%0.02%-43.0%Q4 2016
BIIBBiogen Inc.$5.95M1.66%0.01%Not reportedQ4 2016
RVNCRevance Therapeutics, Inc.$5.89M1.64%0.22%+52.5%Q3 2022
BMRNBiomarin Pharmaceutical Inc$5.7M1.59%0.03%+34.4%Q4 2016
DYNDyne Therapeutics, Inc.$4.99M1.39%0.74%-32.3%Q1 2021
ONCBeOne Medicines Ltd.$4.89M1.37%0.00%+44.6%Q1 2017
KRYSKrystal Biotech, Inc.$4.88M1.36%0.24%+35.6%Q4 2021
GILDGilead Sciences, Inc.$4.78M1.33%0.00%Not reportedQ4 2016
AZNAstrazeneca PLC$4.51M1.26%Not reportedNot reportedQ4 2022
PTCTPTC Therapeutics, Inc.$4.5M1.26%0.13%-35.4%Q1 2019
ERASErasca, Inc.$4.28M1.19%0.95%NewQ1 2023
ACADAcadia Pharmaceuticals Inc$4.06M1.13%0.13%+116.0%Q4 2016
GMABGenmab A/S$3.32M0.93%Not reportedNot reportedQ2 2022
TVTXTravere Therapeutics, Inc.$3.17M0.88%0.19%-62.8%Q4 2020
ASNDAscendis Pharma A/S$3.15M0.88%0.05%Not reportedQ1 2019
ZLABZai Lab Ltd$2.63M0.73%0.01%Not reportedQ2 2021
JAZZJazz Pharmaceuticals plc$2.51M0.70%0.03%Not reportedQ4 2016
CRBUCaribou Biosciences, Inc.$2.43M0.68%0.75%+77.6%Q2 2022
APLSApellis Pharmaceuticals, Inc.$2.09M0.58%0.03%Not reportedQ1 2021
KRTXKaruna Therapeutics, Inc.$2M0.56%0.03%Not reportedQ2 2022
DNLIDenali Therapeutics Inc.$1.99M0.56%0.06%+127.8%Q4 2021
NVCRNovoCure Ltd$1.92M0.54%0.03%Not reportedQ4 2019
LEGNLegend Biotech Corp$1.83M0.51%0.01%Not reportedQ3 2021
GHGuardant Health, Inc.$1.75M0.49%0.07%Not reportedQ2 2021
HALOHalozyme Therapeutics, Inc.$1.74M0.48%0.03%Not reportedQ4 2016
MIRMMirum Pharmaceuticals, Inc.$1.62M0.45%0.18%Not reportedQ3 2022
CRSPCRISPR Therapeutics AG$1.55M0.43%0.04%Not reportedQ4 2019
IONSIonis Pharmaceuticals Inc$1.54M0.43%0.03%Not reportedQ1 2017
RCKTRocket Pharmaceuticals, Inc.$1.08M0.30%0.08%Not reportedQ3 2021
NBPNovaBridge Biosciences$1.07M0.30%0.16%Not reportedQ1 2021
NVAXNovavax Inc$925K0.26%0.15%Not reportedQ2 2022
XENEXenon Pharmaceuticals Inc.$912K0.25%0.04%Not reportedQ2 2021
NTLAIntellia Therapeutics, Inc.$894K0.25%0.03%Not reportedQ4 2021
Q4 2022Reported Feb 1, 202360 positions
HZNPHorizon Therapeutics Public Ltd Co$35.8M11.07%0.14%-30.8%Q4 2016
INCYIncyte Corp$18.4M5.68%0.10%-20.8%Q4 2016
ALKSAlkermes plc.$15.5M4.78%0.36%Not reportedQ1 2019
HRMYHarmony Biosciences Holdings, Inc.$14.6M4.50%0.44%Not reportedQ2 2021
QUREuniQure N.V.$14.3M4.42%1.34%+16.0%Q2 2019
SUPNSupernus Pharmaceuticals, Inc.$13.7M4.22%0.71%+28.9%Q1 2017
ITCIIntra-Cellular Therapies, Inc.$11.7M3.62%0.23%Not reportedQ1 2020
MRTXMirati Therapeutics, Inc.$11.1M3.41%0.42%+79.4%Q1 2019
ILMNIllumina, Inc.$9.4M2.90%0.03%+86.0%Q4 2016
ALNYAlnylam Pharmaceuticals, Inc.$9.02M2.79%0.03%Not reportedQ3 2017
EXELExelixis, Inc.$8.71M2.69%0.17%Not reportedQ4 2016
REGNRegeneron Pharmaceuticals, Inc.$8.08M2.50%0.01%Not reportedQ4 2016
RAREUltragenyx Pharmaceutical Inc.$8.06M2.49%0.25%Not reportedQ1 2018
TVTXTravere Therapeutics, Inc.$7.96M2.46%0.59%+103.8%Q4 2020
DYNDyne Therapeutics, Inc.$7.42M2.29%1.15%+83.1%Q1 2021
SNYSanofi$6.94M2.14%0.01%Not reportedQ2 2022
BIIBBiogen Inc.$5.92M1.83%0.01%-53.0%Q4 2016
PTCTPTC Therapeutics, Inc.$5.49M1.70%0.20%+585.7%Q1 2019
VERAVera Therapeutics, Inc.$5.43M1.68%1.02%Not reportedQ4 2021
GILDGilead Sciences, Inc.$4.94M1.53%0.00%-72.4%Q4 2016
BMRNBiomarin Pharmaceutical Inc$4.51M1.39%0.02%-25.6%Q4 2016
AZNAstrazeneca PLC$4.41M1.36%Not reportedNewQ4 2022
AMGNAmgen Inc$4.27M1.32%0.00%Not reportedQ4 2016
UTHRUNITED THERAPEUTICS Corp$4.17M1.29%0.03%Not reportedQ1 2021
ASNDAscendis Pharma A/S$3.59M1.11%0.05%Not reportedQ1 2019
KRYSKrystal Biotech, Inc.$3.56M1.10%0.17%Not reportedQ4 2021
ONCBeOne Medicines Ltd.$3.45M1.07%0.00%Not reportedQ1 2017
JAZZJazz Pharmaceuticals plc$2.74M0.85%0.03%Not reportedQ4 2016
AUPHAurinia Pharmaceuticals Inc.$2.48M0.77%0.40%Not reportedQ3 2020
ZLABZai Lab Ltd$2.42M0.75%0.01%Not reportedQ2 2021
NVCRNovoCure Ltd$2.34M0.72%0.03%Not reportedQ4 2019
RVNCRevance Therapeutics, Inc.$2.21M0.68%0.15%Not reportedQ3 2022
GHGuardant Health, Inc.$2.02M0.63%0.07%Not reportedQ2 2021
IDYAIDEAYA Biosciences, Inc.$1.98M0.61%0.23%Not reportedQ3 2021
LEGNLegend Biotech Corp$1.89M0.59%0.01%Not reportedQ3 2021
APLSApellis Pharmaceuticals, Inc.$1.64M0.51%0.03%Not reportedQ1 2021
CRBUCaribou Biosciences, Inc.$1.62M0.50%0.42%Not reportedQ2 2022
ACADAcadia Pharmaceuticals Inc$1.59M0.49%0.06%Not reportedQ4 2016
FULCFulcrum Therapeutics, Inc.$1.41M0.44%0.37%Not reportedQ4 2021
CRSPCRISPR Therapeutics AG$1.39M0.43%0.04%Not reportedQ4 2019
ACETAdicet Bio, Inc.$1.38M0.43%0.36%Not reportedQ3 2022
NVAXNovavax Inc$1.36M0.42%0.15%Not reportedQ2 2022
MIRMMirum Pharmaceuticals, Inc.$1.31M0.41%0.18%+632.2%Q3 2022
NBPNovaBridge Biosciences$1.29M0.40%0.16%-38.8%Q1 2021
RCKTRocket Pharmaceuticals, Inc.$1.23M0.38%0.08%Not reportedQ3 2021
CNCEConcert Pharmaceuticals, Inc.$1.17M0.36%0.42%Not reportedQ2 2019
DNLIDenali Therapeutics Inc.$1.06M0.33%0.03%Not reportedQ4 2021
XENEXenon Pharmaceuticals Inc.$1M0.31%0.04%Not reportedQ2 2021
HCMHUTCHMED (China) Ltd$1M0.31%0.01%Not reportedQ2 2021
BEAMBeam Therapeutics Inc.$919K0.28%0.03%Not reportedQ2 2022
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.